RxDoctor Payments Data

Hector Lopez Huertas, MD

Urology · Bayamon, PRNPI 1467660936

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,462 of the $5,705 with a category attached, or 78.2%. It is spread thinly across 17 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations.

$5,705in general payments, 2019–2025

Across 71 payments — averaging $80.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Teleflex LLC$1K
  • Procept Biorobotics Corporation$731
  • Verity Pharmaceuticals Inc.$558
  • Johnson & Johnson$468
  • Travere Therapeutics, Inc.$236
  • plus $1K from 11 others

What the payments were for

  • Travel & lodging$95917%
  • Food & beverage$4,46278%
  • Education$2845%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific19$1,298
Teleflex LLC12$1,056
Procept Biorobotics Corporation1$731
Verity Pharmaceuticals Inc.7$558
Johnson & Johnson(2 entities)7$468
Travere Therapeutics, Inc.3$236
Olympus Latin America, Inc.2$199
Tolmar, Inc.4$186
Neotract Inc.2$159
Medtronic2$158
BD1$130
Merck1$124
Pfizer3$120
AbbVie(2 entities)2$110
E.r. Squibb & Sons, L.L.C.1$100
Ferring Pharmaceuticals Inc.3$50
Johnson And Johnson International1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,705 in reported general payments places this provider in the 75th percentile of 122 urology providers in Puerto Rico.

See all urology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$44,080
Medicare patients
138
Services billed
373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron65$32,202
Tadalafil234$27,176
Tamsulosin Hcl475$5,161
Alfuzosin Hcl ErAlfuzosin Hcl345$4,512
Finasteride256$2,863
Tolterodine Tartrate ErTolterodine Tartrate38$2,163
Cefadroxil228$1,805
Testosterone Cypionate40$1,682
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip49$1,617
Sildenafil Citrate58$1,203
Ciprofloxacin Hcl133$979
Ketorolac Tromethamine47$830
Potassium Citrate ErPotassium Citrate13$517
Levofloxacin14$226
Oxybutynin Chloride22$222

Paid to pharmacies, not to this prescriber.

Other urology in Bayamon

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →